AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
07/12/2022 | Press release | Distributed by Public on 07/12/2022 16:54
Please select the service you want to use:
Smartlinks | Toyota Financial Services Mexico SA de CV | Toyota Motor Corporation | Company News | Private Companies | Consumer Lending Companies
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact